Genome-Wide Association Study for Glucocorticoid-Induced Ocular Hypertension

Request Access

Demographics (5)

AGE - Subject age at enrollment (phv00562972.v1.p1)
AGE - Subject age at enrollment (phv00563003.v1.p1)
SEX - Subject's sex (phv00562971.v1.p1)
SEX - Subject's sex (phv00563002.v1.p1)
SEX - Biological sex (phv00562966.v1.p1)

Disease Events (6)

DIABETES - Diabetes status at enrollment (phv00562998.v1.p1)
DIABETES - Diabetes status at enrollment (phv00563029.v1.p1)
FAMILY_HX_GLAUCOMA - Family history of glaucoma at enrollment (phv00562983.v1.p1)
FAMILY_HX_GLAUCOMA - Family history of glaucoma at enrollment (phv00563014.v1.p1)
HYPERTENSION - Hypertension status at enrollment (phv00562999.v1.p1)
HYPERTENSION - Hypertension status at enrollment (phv00563030.v1.p1)

General Health (26)

BASELINE_IOP - Intraocular pressure at enrollment (phv00562989.v1.p1)
BASELINE_IOP - Intraocular pressure at enrollment (phv00563020.v1.p1)
GLAUCOMA_OR_OCULAR_HYPERTENSION - Glaucoma or ocular hypertension status at enrollment (phv00562981.v1.p1)
GLAUCOMA_OR_OCULAR_HYPERTENSION - Glaucoma or ocular hypertension status at enrollment (phv00563012.v1.p1)
GLAUCOMA_SX_AFTER_STEROID - Glaucoma symptoms after steroid medication (phv00562985.v1.p1)
GLAUCOMA_SX_AFTER_STEROID - Glaucoma symptoms after steroid medication (phv00563016.v1.p1)
GLAUCOMA_SX_PRIOR_STEROID - Glaucoma symptoms before steroid medication (phv00562984.v1.p1)
GLAUCOMA_SX_PRIOR_STEROID - Glaucoma symptoms before steroid medication (phv00563015.v1.p1)
GLAUCOMA_TYPE - Glaucoma type at enrollment (phv00562982.v1.p1)
GLAUCOMA_TYPE - Glaucoma type at enrollment (phv00563013.v1.p1)
IOP_1MO - Intraocular pressure 1 month after steroid medication (phv00562991.v1.p1)
IOP_1MO - Intraocular pressure 1 month after steroid medication (phv00563022.v1.p1)
IOP_1WK - Intraocular pressure 1 week after steroid medication (phv00562990.v1.p1)
IOP_1WK - Intraocular pressure 1 week after steroid medication (phv00563021.v1.p1)
IOP_2MO - Intraocular pressure 2 months after steroid medication (phv00562992.v1.p1)
IOP_2MO - Intraocular pressure 2 months after steroid medication (phv00563023.v1.p1)
IOP_3MO - Intraocular pressure 3 months after steroid medication (phv00562993.v1.p1)
IOP_3MO - Intraocular pressure 3 months after steroid medication (phv00563024.v1.p1)
IOP_6MO - Intraocular pressure 6 months after steroid medication (phv00562994.v1.p1)
IOP_6MO - Intraocular pressure 6 months after steroid medication (phv00563025.v1.p1)
IOP_DROPS_AFTER_STEROID - Intraocular pressure lowering drop use after to steroid medication (phv00562987.v1.p1)
IOP_DROPS_AFTER_STEROID - Intraocular pressure lowering drop use after to steroid medication (phv00563018.v1.p1)
IOP_DROPS_PRIOR_STEROID - Intraocular pressure lowering drop use prior to steroid medication (phv00562986.v1.p1)
IOP_DROPS_PRIOR_STEROID - Intraocular pressure lowering drop use prior to steroid medication (phv00563017.v1.p1)
IOP_DROPS_WITIHIN_6MO_FOLLOWUP - Intraocular pressure lowering drop use during 6 months following steroid medication (phv00562988.v1.p1)
IOP_DROPS_WITIHIN_6MO_FOLLOWUP - Intraocular pressure lowering drop use during 6 months following steroid medication (phv00563019.v1.p1)

Race and Ethnicity (4)

ETHNICITY - Self-reported ethnicity (phv00562974.v1.p1)
ETHNICITY - Self-reported ethnicity (phv00563005.v1.p1)
RACE - Self-reported race (phv00562973.v1.p1)
RACE - Self-reported race (phv00563004.v1.p1)

Other (30)

AFFECTION_STATUS - Steroid responder status (phv00562970.v1.p1)
AFFECTION_STATUS - Steroid responder status (phv00563001.v1.p1)
ANALYTE_TYPE - Analyte type (phv00563033.v1.p1)
BODY_SITE - Body site where sample was collected (phv00563032.v1.p1)
CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body. (phv00562965.v1.p1)
DOSE - Dose of primary steroid exposure medication (phv00562979.v1.p1)
DOSE - Dose of primary steroid exposure medication (phv00563010.v1.p1)
EXTREME_STEROID_NONRESPONDER - Extreme steroid nonresponder status (phv00562997.v1.p1)
EXTREME_STEROID_NONRESPONDER - Extreme steroid nonresponder status (phv00563028.v1.p1)
EXTREME_STEROID_RESPONDER - Extreme steroid responder status (phv00562996.v1.p1)
EXTREME_STEROID_RESPONDER - Extreme steroid responder status (phv00563027.v1.p1)
EYE - Eye of interest (phv00562975.v1.p1)
EYE - Eye of interest (phv00563006.v1.p1)
IS_TUMOR - Tumor status (phv00563034.v1.p1)
MAX_IOP_CHANGE - Maximum intaocular pressure change within 6 month follow-up period (phv00562995.v1.p1)
MAX_IOP_CHANGE - Maximum intaocular pressure change within 6 month follow-up period (phv00563026.v1.p1)
OTHER_STEROID_INDICATION - Other diagnosis associated with steroid medication (phv00562977.v1.p1)
OTHER_STEROID_INDICATION - Other diagnosis associated with steroid medication (phv00563008.v1.p1)
PRIMARY_STEROID_MEDICATION - Primary steroid exposure medication (phv00562978.v1.p1)
PRIMARY_STEROID_MEDICATION - Primary steroid exposure medication (phv00563009.v1.p1)
SAMPLE_ID - Sample ID (phv00563031.v1.p1)
SAMPLE_ID - Sample ID for whole exome sequencing and global screening array data (phv00562968.v1.p1)
SECONDARY_STEROID_MEDICATION - Secondary steroid exposure medication (phv00562980.v1.p1)
SECONDARY_STEROID_MEDICATION - Secondary steroid exposure medication (phv00563011.v1.p1)
STEROID_INDICATION - Diagnosis associated with steroid medication (phv00562976.v1.p1)
STEROID_INDICATION - Diagnosis associated with steroid medication (phv00563007.v1.p1)
SUBJECT_ID - Subject ID (phv00562969.v1.p1)
SUBJECT_ID - Subject ID (phv00563000.v1.p1)
SUBJECT_ID - Subject ID (phv00562964.v1.p1)
SUBJECT_ID - Subject ID (phv00562967.v1.p1)